Melanoma

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

For patients diagnosed with metastatic melanoma, the lifetime incidence of…

Expiration Date: 4/30/2020

Max Credits: 0

View Activity

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

The development and integration of targeted therapies, as well as immunoth…

Expiration Date: 4/10/2018

Max Credits: 0

View Activity

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

The integration of immune checkpoint inhibitors into treatment strategies …

Expiration Date: 2/23/2018

Max Credits: 0

View Activity

Combination Strategies in Melanoma Management: What's New and What's Next

Combination Strategies in Melanoma Management: What's New and What's Next

Melanoma is the sixth most common cancer in the United States and the dead…

Expiration Date: 1/23/2018

Max Credits: 0

View Activity

Emerging Trends in the Sequencing and Combination of Therapies for Advanced Melanoma

Emerging Trends in the Sequencing and Combination of Therapies for Advanced Melanoma

Melanoma is the sixth most common cancer in the United States, and the num…

Expiration Date: 9/23/2017

Max Credits: 0

View Activity

Adjuvant Therapy for High-Risk Melanoma

Adjuvant Therapy for High-Risk Melanoma

Systemic adjuvant therapy targets melanoma micrometastases in patients who…

Expiration Date: 3/27/2017

Max Credits: 0

View Activity

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Melanoma is the deadliest form of skin cancer. Historically, treatment opt…

Expiration Date: 2/25/2017

Max Credits: 0

View Activity

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Melanoma is the deadliest form of skin cancer. Historically, treatment opt…

Expiration Date: 2/25/2017

Max Credits: 0

View Activity

The Role of Intralesional Therapy for Patients with Melanoma

The Role of Intralesional Therapy for Patients with Melanoma

This CME/CNE activity will review the role of intralesional therapy in pat…

Expiration Date: 2/16/2017

Max Credits: 0

View Activity

Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma

Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma

This CME/CNE activity will discuss the role of checkpoint inhibitor therap…

Expiration Date: 2/16/2017

Max Credits: 0

View Activity